AI patent eligibility under Section 101

AI-Assisted Inventions and U.S. Patent Eligibility Under Section 101

AI patent eligibility under Section 101 is determined by a two-step framework that asks whether your claims are directed to an abstract idea and, if so, whether they add something more. The 2024 USPTO guidance gives applicants specific examples of what passes and what does not. Understanding that guidance before you file...

AI-Assisted Inventions and U.S. Patent Eligibility Under Section 101 Continue reading…
Richard Gearhart Presents on Intellectual Property Risk at NJSBA Summer Conference

Richard Gearhart Presents on Intellectual Property Risk at NJSBA Summer Conference

Gearhart Law founding partner shares insights on spotting 12 IP red flags before major business transactions at NJSBA Summer Conference

Summit, NJ — August 20, 2026 — Richard Gearhart, Esq. of Gearhart Law, LLC, presented at the New Jersey State Bar Association's (NJSBA) 2026 Summer Conference, a virtual Continuing Legal Education (CLE) event held...

Richard Gearhart Presents on Intellectual Property Risk at NJSBA Summer Conference Continue reading…
Protecting Biotechnology and Medical Research Under U.S. Patent Law

Protecting Biotechnology and Medical Research Under U.S. Patent Law

Biotechnology patent protection in the USA is not just about whether an invention is patentable. For research institutions, universities, and companies working on federally funded projects, ownership, disclosure timing, and collaboration agreements can determine who actually controls the resulting patent.

Most conversations about biotechnology patent protection in the...

Protecting Biotechnology and Medical Research Under U.S. Patent Law Continue reading…
Life Sciences Patent Applications

Life Sciences Patent Applications: Avoiding Common Prosecution Pitfalls at the USPTO

Most life sciences patent applications that run into trouble at the USPTO do not fail because the science is weak. They fail because of avoidable mistakes in the specification, the claims, or the prosecution process itself. This post covers the pitfalls that show up most often and what to do about...

Life Sciences Patent Applications: Avoiding Common Prosecution Pitfalls at the USPTO Continue reading…
Patent Eligibility May Be About to Change: What PERA Could Mean for Innovators

Patent Eligibility May Be About to Change: What PERA Could Mean for Innovators

Senate Judiciary Committee Hears PERA Testimony

Intellectual property law may be changing in a big way. On July 14, 2026 the Senate Judiciary Committee heard testimony on PERA which stands for Patent Eligibility Restoration Act of 2025. Hopefully they’ll update the title to "2026" if it becomes law...

Patent Eligibility May Be About to Change: What PERA Could Mean for Innovators Continue reading…
Patent Protection for Biotech Inventions

Patent Protection for Biotech Inventions: Prosecution Strategies for Life Sciences Companies

Biotech patent prosecution is the legal process of getting a patent application examined and granted by the USPTO. It starts with claim drafting and runs through every Office Action, examiner interview, and continuation decision. The companies that build the strongest biotech patent portfolios are the ones that treat prosecution as a long...

Patent Protection for Biotech Inventions: Prosecution Strategies for Life Sciences Companies Continue reading…
USPTO's Foreign Trademark Rules

USPTO’s Foreign Trademark Rules: A Guide for Non-U.S. Businesses Entering the American Market

The United States Patent and Trademark Office (USPTO) has specific rules that apply only to foreign applicants, from mandatory U.S. attorney representation to how your domicile is determined, how your goods and services must be described, and what you need to do to keep your registration alive after it is granted.

USPTO’s Foreign Trademark Rules: A Guide for Non-U.S. Businesses Entering the American Market Continue reading…
Trademark Filing Requirements for Foreign Companies

Trademark Filing Requirements for Foreign Companies: USPTO’s U.S.-Licensed Attorney Rule

If your business is based outside the United States, U.S. trademark filing requirements include working with a U.S.-licensed attorney at every stage. Filing without one risks abandonment of your application and cancellation of your registration.

The United States Patent and Trademark Office (USPTO) requires all foreign-domiciled applicants to be...

Trademark Filing Requirements for Foreign Companies: USPTO’s U.S.-Licensed Attorney Rule Continue reading…